Please wait while we open this resource.
K
Clinical reviews
SAFETY OF RHEUMATIC DISEASE MEDICATION USE DURING PREGNANCY
Bonnie L Bermas, MD
PDF202648 pages476 KB
Inflammatory disorders such as rheumatoid arthritis, systemic lupus erythematosus, and inflammatory bowel disease often affect women of childbearing age, making the management of these conditions during pregnancy crucial. The document discusses the relative benefits and risks of various anti-inflammatory, immunosuppressive, and biologic medications, emphasizing the importance of individualized treatment plans based on clinical context and gestational age. It also addresses strategies for preserving fertility in patients undergoing cytotoxic therapy.
Sign in to open
Ask this resource
Answers use this document only.
Your first question is free.
More like this
Resources from the same specialty and type. Curated links will replace these when added.
Clinical Resources
Documents that extend or complement this resource.
Repurposing leflunomide and hydroxychloroquine to treat Sjögren's disease (RepurpSS-II): a randomised, double-blind, placebo-controlled, phase 2b trial
Same clinical topic · Rheumatology
EARLY TRAUMA AS THE ORIGIN OF CHRONIC INFLAMMATION: A PSYCHONEUROIMMUNOLOGICAL PERSPECTIVE
Same clinical topic · Rheumatology
IDIOPATHIC INFLAMMATORY MYOPATHIES
Same clinical topic · Rheumatology
MULTIFACTORIAL PATHOGENESIS OF RHEUMATOID ARTHRITIS
Same clinical topic · Rheumatology
SYSTEMIC LUPUS ERYTHEMATOSUS IN CRITICAL CARE: A SYSTEMATIC REVIEW OF ICU OUTCOMES AND MANAGEMENT
Same clinical topic · Rheumatology
RHEUMATOID ARTHRITIS — COMMON ORIGINS, DIVERGENT MECHANISMS
Same clinical topic · Rheumatology
RHEUMATOID ARTHRITIS IN ADULTS
Same clinical topic · Rheumatology
BIOLOGICAL THERAPY IN SYSTEMIC LUPUS ERYTHEMATOSUS
Same clinical topic · Rheumatology
SYSTEMIC LUPUS ERYTHEMATOSUS: DIAGNOSIS AND TREATMENT
Same clinical topic · Rheumatology